Literature DB >> 18571098

Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.

Femke M S de Vrij1, Josien Levenga, Herma C van der Linde, Sebastiaan K Koekkoek, Chris I De Zeeuw, David L Nelson, Ben A Oostra, Rob Willemsen.   

Abstract

Lack of fragile X mental retardation protein (FMRP) causes Fragile X Syndrome, the most common form of inherited mental retardation. FMRP is an RNA-binding protein and is a component of messenger ribonucleoprotein complexes, associated with brain polyribosomes, including dendritic polysomes. FMRP is therefore thought to be involved in translational control of specific mRNAs at synaptic sites. In mice lacking FMRP, protein synthesis-dependent synaptic plasticity is altered and structural malformations of dendritic protrusions occur. One hypothesized cause of the disease mechanism is based on exaggerated group I mGluR receptor activation. In this study, we examined the effect of the mGluR5 antagonist MPEP on Fragile X related behavior in Fmr1 KO mice. Our results demonstrate a clear defect in prepulse inhibition of startle in Fmr1 KO mice, that could be rescued by MPEP. Moreover, we show for the first time a structural rescue of Fragile X related protrusion morphology with two independent mGluR5 antagonists.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18571098      PMCID: PMC2481236          DOI: 10.1016/j.nbd.2008.04.002

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  47 in total

1.  Internalization of ionotropic glutamate receptors in response to mGluR activation.

Authors:  E M Snyder; B D Philpot; K M Huber; X Dong; J R Fallon; M F Bear
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

2.  Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons.

Authors:  M Matsuzaki; G C Ellis-Davies; T Nemoto; Y Miyashita; M Iino; H Kasai
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

3.  Monitoring kinetic and frequency-domain properties of eyelid responses in mice with magnetic distance measurement technique.

Authors:  S K E Koekkoek; W L Den Ouden; G Perry; S M Highstein; C I De Zeeuw
Journal:  J Neurophysiol       Date:  2002-10       Impact factor: 2.714

4.  Abnormal development of dendritic spines in FMR1 knock-out mice.

Authors:  E A Nimchinsky; A M Oberlander; K Svoboda
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

5.  Transport of fragile X mental retardation protein via granules in neurites of PC12 cells.

Authors:  Yolanda De Diego Otero; Lies-Anne Severijnen; Gert van Cappellen; Mariëtte Schrier; Ben Oostra; Rob Willemsen
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

6.  Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function.

Authors:  J C Darnell; K B Jensen; P Jin; V Brown; S T Warren; R B Darnell
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

Review 7.  Synaptic regulation of protein synthesis and the fragile X protein.

Authors:  W T Greenough; A Y Klintsova; S A Irwin; R Galvez; K E Bates; I J Weiler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

8.  Altered synaptic plasticity in a mouse model of fragile X mental retardation.

Authors:  Kimberly M Huber; Sean M Gallagher; Stephen T Warren; Mark F Bear
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

9.  RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice.

Authors:  Kevin Y Miyashiro; Andrea Beckel-Mitchener; T Patrick Purk; Kevin G Becker; Tanya Barret; Lei Liu; Salvatore Carbonetto; Ivan Jeanne Weiler; William T Greenough; James Eberwine
Journal:  Neuron       Date:  2003-02-06       Impact factor: 17.173

10.  The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity.

Authors:  S A Henry; V Lehmann-Masten; F Gasparini; M A Geyer; A Markou
Journal:  Neuropharmacology       Date:  2002-12       Impact factor: 5.250

View more
  164 in total

1.  Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome.

Authors:  Laura K K Pacey; Sujeenthar Tharmalingam; David R Hampson
Journal:  J Pharmacol Exp Ther       Date:  2011-06-02       Impact factor: 4.030

2.  Delayed stabilization of dendritic spines in fragile X mice.

Authors:  Alberto Cruz-Martín; Michelle Crespo; Carlos Portera-Cailliau
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 3.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

4.  Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.

Authors:  S M Goebel-Goody; E D Wilson-Wallis; S Royston; S M Tagliatela; J R Naegele; P J Lombroso
Journal:  Genes Brain Behav       Date:  2012-04-06       Impact factor: 3.449

Review 5.  The trouble with spines in fragile X syndrome: density, maturity and plasticity.

Authors:  C X He; C Portera-Cailliau
Journal:  Neuroscience       Date:  2012-04-20       Impact factor: 3.590

Review 6.  Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

Authors:  Susan B Powell; Martin Weber; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 7.  Potential therapeutic interventions for fragile X syndrome.

Authors:  Josien Levenga; Femke M S de Vrij; Ben A Oostra; Rob Willemsen
Journal:  Trends Mol Med       Date:  2010-09-21       Impact factor: 11.951

Review 8.  Stem cells and modeling of autism spectrum disorders.

Authors:  Beatriz C G Freitas; Cleber A Trujillo; Cassiano Carromeu; Marianna Yusupova; Roberto H Herai; Alysson R Muotri
Journal:  Exp Neurol       Date:  2012-10-02       Impact factor: 5.330

Review 9.  FMR1: a gene with three faces.

Authors:  Ben A Oostra; Rob Willemsen
Journal:  Biochim Biophys Acta       Date:  2009-02-21

10.  Environmental enrichment reveals effects of genotype on hippocampal spine morphologies in the mouse model of Fragile X Syndrome.

Authors:  Julie C Lauterborn; Matiar Jafari; Alex H Babayan; Christine M Gall
Journal:  Cereb Cortex       Date:  2013-09-17       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.